Browsing HMS Scholarly Articles by Keyword "Bevacizumab"
Now showing items 1-2 of 2
-
Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication
(BioMed Central, 2014)Background: Homeobox B9 (HOXB9), a transcriptional factor, regulates developmental processes and tumor progression and has recently been recognized as one of important transcriptional factors related to angiogenesis. This ... -
Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation
(BlackWell Publishing Ltd, 2015)The NovoTTF-100A is a device that emits alternating electric fields and it is approved for the treatment of recurrent glioblastoma. It works by perturbing tumor cells during mitosis as they enter anaphase leading to ...